Opko Health OPK
NASDAQ OPK
$1.63 +0.03 (+1.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Opko Health (OPK) Liabilities from Discontinued Operations (2011 - 2012)

Updated

Opko Health (OPK) reported Liabilities from Discontinued Operations of $1,000 for Q3 2012, down 98.9% from the prior quarter.

Analysis

Opko Health (OPK) Liabilities from Discontinued Operations (2011 - 2012) Analysis & Trends

At the end of FY2011, Opko Health posted Liabilities from Discontinued Operations of $174,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Opko Health 1.22 Bn -210.40 Mn 80.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 1,000.00
Jun 30, 2012 87,000.00
Dec 31, 2011 174,000.00
API Access

Opko Health Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=OPK&period=max&api_key=YOUR_API_KEY